Qlife Holding AB (publ)

Stockholm Stock Exchange QLIFE.ST

Qlife Holding AB (publ) Net Income Margin for the year ending December 31, 2023: -65,555.74%

Qlife Holding AB (publ) Net Income Margin is -65,555.74% for the year ending December 31, 2023, a -12,564.07% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Qlife Holding AB (publ) Net Income Margin for the year ending December 31, 2022 was -517.65%, a -428.54% change year over year.
Qlife Holding AB (publ) Net Income Margin for the year ending December 31, 2021 was -97.94%, a -0.61% change year over year.
Qlife Holding AB (publ) Net Income Margin for the year ending December 31, 2020 was -97.35%, a -114.52% change year over year.
Qlife Holding AB (publ) Net Income Margin for the year ending December 31, 2019 was -45.38%.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

Stockholm Stock Exchange: QLIFE.ST

Qlife Holding AB (publ)

CEO	Mr. Thomas Warthoe
IPO Date	March 2, 2020
Location	Sweden
Headquarters	Redaregatan 48
Employees	24
Sector	Health Care
Industries Pharmaceuticals Biotechnology Medical Instruments

Description

Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo.Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus. Its biomarkers include C-reactive protein home-testing capsule, PHE/Phenylalanine for PKU patients, and Sars-CoV-2/Influenza multiplex for virus/bacteria tests. The company was incorporated in 2019 and is based in Helsingborg, Sweden.

Key trends

Past 5 years